KLEPTOSE HPB for parenteral uses, low molar substitution. It is a pyrogen-free solution that improves drug solubility and stability against light or oxidation by molecular encapsulation. It also reduces irritation at injection site. White or almost white amorphous powder. The statistical hydroxypropylation of beta-cyclodextrin creates a multitude of molecules differing by the position of the hydroxypropyl groups. Consequently, the product is not able to crystallize and remains in the amorphous state. EP/USP compliance.